Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1770
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV